Paper15545971
Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis.
Martin B and 7 others. Br J Cancer, 2004. Cited by 234 papers, by iCite.
Cite this record
ConductScience Library. Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis. Papers, record 15545971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15545971
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Ki-67 Antigen | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Prognosis | |
| Survival Analysis |
Source PubMed
References86
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3813259 | The medical review article: state of the science. | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3813259 | PubMed |
| 2 | 10448663 | Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. | Pathol Res Pract | 1999 | https://conductscience.org/library/papers/10448663 | PubMed |
| 3 | 11432756 | Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. | BMC Cancer | 2001 | https://conductscience.org/library/papers/11432756 | PubMed |
| 4 | 12124571 | Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery. | J Cardiovasc Surg (Torino) | 2002 | https://conductscience.org/library/papers/12124571 | PubMed |
| 5 | 9305703 | The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. | Cancer | 1997 | https://conductscience.org/library/papers/9305703 | PubMed |
| 6 | 9531362 | Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. | Int J Radiat Oncol Biol Phys | 1998 | https://conductscience.org/library/papers/9531362 | PubMed |
| 7 | 9251637 | Language bias in randomised controlled trials published in English and German. | Lancet | 1997 | https://conductscience.org/library/papers/9251637 | PubMed |
| 8 | 12887508 | Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies. | APMIS | 2003 | https://conductscience.org/library/papers/12887508 | PubMed |
| 9 | 10861611 | Biological prognostic factors for early stage completely resected non-small cell lung cancer. | J Surg Oncol | 2000 | https://conductscience.org/library/papers/10861611 | PubMed |
| 10 | 11557114 | High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients. | Lung Cancer | 2001 | https://conductscience.org/library/papers/11557114 | PubMed |
| 11 | 10443734 | Tumor cell proliferation in prostate cancer after 3 months of neoadjuvant LHRH analogue treatment is a prognostic marker of recurrence after radical prostatectomy. | Urology | 1999 | https://conductscience.org/library/papers/10443734 | PubMed |
| 12 | 10473085 | Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. | Clin Cancer Res | 1999 | https://conductscience.org/library/papers/10473085 | PubMed |
| 13 | 10441603 | Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. | N Engl J Med | 1999 | https://conductscience.org/library/papers/10441603 | PubMed |
| 14 | 8633961 | Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. | Ann Thorac Surg | 1996 | https://conductscience.org/library/papers/8633961 | PubMed |
| 15 | 9436967 | Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung. | Mod Pathol | 1997 | https://conductscience.org/library/papers/9436967 | PubMed |
| 16 | 11155917 | Useful prognostic panel markers to express the biological tumor status in resected lung adenocarcinomas. | Jpn J Clin Oncol | 2000 | https://conductscience.org/library/papers/11155917 | PubMed |
| 17 | 9711528 | Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer. | Lung Cancer | 1998 | https://conductscience.org/library/papers/9711528 | PubMed |
| 18 | 11008007 | A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis. | Lung Cancer | 2000 | https://conductscience.org/library/papers/11008007 | PubMed |
| 19 | 2778823 | Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. | J Natl Cancer Inst | 1989 | https://conductscience.org/library/papers/2778823 | PubMed |
| 20 | 12001111 | Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. | Cancer | 2002 | https://conductscience.org/library/papers/12001111 | PubMed |
Cited by127
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957226 | Prognostic Value of Histology-specific Ki-67 Labeling Index Cutoffs in Stage I-III Non-small Cell Lung Cancer. | In Vivo | 2026 | https://conductscience.org/library/papers/42957226 | PubMed |
| 42512306 | Stratification of Prognosis in Pulmonary Pleomorphic Carcinoma Based on Integrated PD-L1 and Multiparametric Biomarker Analysis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512306 | PubMed |
| 42466117 | Sex differences in the cancer proteome. | BMJ Oncol | 2026 | https://conductscience.org/library/papers/42466117 | PubMed |
| 42449297 | The Ki-67 proliferation index in tertiary lymphoid structures as a predictor of survival outcomes in patients with resectable non-small cell lung cancer. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42449297 | PubMed |
| 42073537 | The Prognostic Impact of the Ki-67 Proliferation Index in Patients with Surgically Treated Spinal Metastases. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42073537 | PubMed |
| 40647543 | Emerging Techniques of Translational Research in Immuno-Oncology: A Focus on Non-Small Cell Lung Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40647543 | PubMed |
| 40594106 | Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594106 | PubMed |
| 40243539 | PI3K and PINK1 Immunoexpression as Predictors of Survival in Patients Undergoing Resection of Brain Metastases from Lung Adenocarcinoma. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243539 | PubMed |
| 40070823 | A comprehensive analysis of the prognostic value, expression characteristics and immune correlation of MKI67 in cancers. | Front Immunol | 2025 | https://conductscience.org/library/papers/40070823 | PubMed |
| 39927285 | Expression of minichromosome maintenance proteins in the exfoliated cells supplement sputum cytology in the diagnosis of lung cancer. | Cytojournal | 2024 | https://conductscience.org/library/papers/39927285 | PubMed |
| 39905556 | Comprehensive genomic and transcriptomic profiling of pulmonary nodules in synchronous multiple primary lung cancer. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/39905556 | PubMed |
| 39673801 | Simulated burn pit smoke condensates cause sustained impact on human airway epithelial cells. | Toxicol Sci | 2025 | https://conductscience.org/library/papers/39673801 | PubMed |
| 39062740 | Uncovering Porphyrin Accumulation in the Tumor Microenvironment. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39062740 | PubMed |
| 38737684 | Identification of risk factors of EGFR-TKIs primary resistance in lung adenocarcinoma patients and construction of a risk predictive model: a case-control study. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/38737684 | PubMed |
| 38343220 | An MRI-Based Deep Transfer Learning Radiomics Nomogram to Predict Ki-67 Proliferation Index of Meningioma. | J Imaging Inform Med | 2024 | https://conductscience.org/library/papers/38343220 | PubMed |
| 38260218 | Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. | Adv Radiat Oncol | 2024 | https://conductscience.org/library/papers/38260218 | PubMed |
| 38001663 | Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts). | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38001663 | PubMed |
| 37835850 | Deep Learning to Predict the Cell Proliferation and Prognosis of Non-Small Cell Lung Cancer Based on FDG-PET/CT Images. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/37835850 | PubMed |
| 37692968 | Association between PD-L1 and Ki-67 expression and clinicopathologic features in NSCLC patients. | Am J Transl Res | 2023 | https://conductscience.org/library/papers/37692968 | PubMed |
| 37665739 | Central and peripheral pulmonary sclerosing pneumocytomas: multi-phase CT study and comparison with Ki-67. | Radiol Oncol | 2023 | https://conductscience.org/library/papers/37665739 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| MIB1 | 57534 | PubTator's text mining | https://conductscience.org/library/genes/57534 | NCBI Gene |
| MKI67 | 4288 | PubTator's text mining | https://conductscience.org/library/genes/4288 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15545971
GET https://conductscience.org/api/papers/v1/15545971/references?page=2